Recalls of compounded and unapproved GLP-1 drugs
openFDA lists 81 drug recall reports from 17 firms for compounded or unapproved GLP-1 products in this index. The most common reason FDA recorded is “Lack of assurance of sterility” (50 reports). Each report is one product line; one recall event can cover several.
| Record | ||||||
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Houston Rx LLC | Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032. | Lack of assurance of sterility. | Class II | Ongoing | D-0040-2027 |
| Sep 24, 2026 | Apothecary Pharma LLC | Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18. | Lack of Assurance of Sterility | Class II | Ongoing | D-0036-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | SEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0026-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | SEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0019-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936 | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0018-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0027-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | TIRZEPATIDE/CYANOCOBALAMIN 85/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0030-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | TIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0028-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | TIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0029-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infus... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0017-2027 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, S... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0755-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 652... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0747-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO ... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0748-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, S... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0753-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO ... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0749-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 652... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0752-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 1... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0757-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 1... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0756-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0751-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 652... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0750-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 10... | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | Ongoing | D-0754-2026 |
| Mar 6, 2026 | PAYLESS COMPOUNDERS, LLC | Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR | Lack of Assurance of Sterility | Class II | Ongoing | D-0471-2026 |
| Feb 26, 2026 | New Life Pharma LLC | Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06 | Lack of Assurance of Sterility | Class II | Ongoing | D-0393-2026 |
| Feb 26, 2026 | New Life Pharma LLC | Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07. | Lack of Assurance of Sterility | Class II | Ongoing | D-0392-2026 |
| Feb 26, 2026 | New Life Pharma LLC | Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04. | Lack of Assurance of Sterility | Class II | Ongoing | D-0395-2026 |
| Feb 26, 2026 | New Life Pharma LLC | Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03. | Lack of Assurance of Sterility | Class II | Ongoing | D-0394-2026 |
| Feb 13, 2026 | Harbin Jixianglong Biotech Co., Ltd. | Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; ... | CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation be... | Class II | Ongoing | D-0380-2026 |
| Feb 13, 2026 | Harbin Jixianglong Biotech Co., Ltd. | Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d... | CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation be... | Class II | Ongoing | D-0379-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 841... | Lack of Assurance of Sterility | Class II | Ongoing | D-0115-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84... | Lack of Assurance of Sterility | Class II | Ongoing | D-0116-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 8413... | Lack of Assurance of Sterility | Class II | Ongoing | D-0118-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84... | Lack of Assurance of Sterility | Class II | Ongoing | D-0117-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139... | Lack of Assurance of Sterility | Class II | Ongoing | D-0114-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 8413... | Lack of Assurance of Sterility | Class II | Ongoing | D-0119-2026 |
| Oct 15, 2025 | ProRx LLC | Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139... | Lack of Assurance of Sterility | Class II | Ongoing | D-0120-2026 |
| Jul 30, 2025 | GenoGenix LLC | Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as m... | Lack of Assurance of Sterility | Class II | Ongoing | D-0091-2026 |
| Jul 30, 2025 | GenoGenix LLC | Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. | Lack of Assurance of Sterility | Class II | Ongoing | D-0083-2026 |
| Jul 30, 2025 | GenoGenix LLC | Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labe... | Lack of Assurance of Sterility | Class II | Ongoing | D-0092-2026 |
| Jul 30, 2025 | GenoGenix LLC | Retatrutide for Injection, 60mg / 10mL vial, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692 | Lack of Assurance of Sterility | Class II | Ongoing | D-0093-2026 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, D... | Lack of Processing Controls. | Class II | Ongoing | D-0563-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dos... | Lack of Processing Controls. | Class II | Ongoing | D-0564-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate,... | Lack of Processing Controls. | Class II | Ongoing | D-0562-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, Multi Dose Vial, Refrigerate, Do n... | Lack of Processing Controls. | Class II | Ongoing | D-0553-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate... | Lack of Processing Controls. | Class II | Ongoing | D-0561-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate,... | Lack of Processing Controls. | Class II | Ongoing | D-0565-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do n... | Lack of Processing Controls. | Class II | Ongoing | D-0555-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do no... | Lack of Processing Controls. | Class II | Ongoing | D-0554-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, D... | Lack of Processing Controls. | Class II | Ongoing | D-0558-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 3 x 2 mL Multi Dose Vial, Refrigerate... | Lack of Processing Controls. | Class II | Ongoing | D-0560-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do ... | Lack of Processing Controls. | Class II | Ongoing | D-0556-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do ... | Lack of Processing Controls. | Class II | Ongoing | D-0557-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do ... | Lack of Processing Controls. | Class II | Ongoing | D-0559-2025 |
| Jul 9, 2025 | Boothwyn Pharmacy LLC | Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy | Subpotent Drug | Class II | Ongoing | D-0608-2025 |
| Jul 9, 2025 | Boothwyn Pharmacy LLC | Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy | Subpotent Drug | Class II | Ongoing | D-0606-2025 |
| Jul 9, 2025 | Boothwyn Pharmacy LLC | Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy | Subpotent Drug | Class II | Ongoing | D-0609-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0480-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0479-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0481-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0484-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0485-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0482-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo... | Lack of Assurance of Sterility | Class II | Ongoing | D-0486-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0483-2025 |
| Aug 22, 2024 | ProRx LLC | Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01 | Lack of Assurance of Sterility | Class II | Ongoing | D-0650-2024 |
| Aug 22, 2024 | ProRx LLC | Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02 | Lack of Assurance of Sterility | Class II | Ongoing | D-0654-2024 |
| Aug 22, 2024 | ProRx LLC | SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-01 | Lack of Assurance of Sterility | Class II | Ongoing | D-0652-2024 |
| Aug 22, 2024 | ProRx LLC | SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-04 | Lack of Assurance of Sterility | Class II | Ongoing | D-0653-2024 |
| Aug 22, 2024 | ProRx LLC | Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01 | Lack of Assurance of Sterility | Class II | Ongoing | D-0651-2024 |
| Aug 22, 2024 | ProRx LLC | TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02 | Lack of Assurance of Sterility | Class II | Ongoing | D-0656-2024 |
| Aug 22, 2024 | ProRx LLC | TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01 | Lack of Assurance of Sterility | Class II | Ongoing | D-0655-2024 |
| Apr 20, 2024 | Revive Rx LLC dba Revive Rx Pharmacy | Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77... | Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate | Class I | Ongoing | D-0511-2024 |
| Aug 15, 2023 | TMC Acquisitions LLC dba Tailor Made Compounding | Semaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials, Tailor Made Compounding. | Lack of Assurance of Sterility | Class II | Terminated | D-1105-2023 |
| May 11, 2023 | Revive Rx LLC dba Revive Rx Pharmacy | Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, N... | Sub-potent Drug | Class II | Ongoing | D-0771-2023 |
| Apr 13, 2023 | Pharmacy Plus, Inc. dba Vital Care Compounder | C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402 | Lack of assurance of sterility. | Class II | Ongoing | D-0538-2023 |
| Dec 22, 2022 | Pharmacy Innovations | SEMAGLUTIDE 0.5MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 1MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 2MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 4MG/ML (0.5ML ... | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. | Class II | Terminated | D-0236-2023 |
| Oct 7, 2022 | Pharmacy Plus, Inc. dba Vital Care Compounder | SEMAGLUTIDE INJECTION 5MG/ML (0.25MG/0.05ML) SOLN, various amounts in unit dose vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402 | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility ... | Class II | Ongoing | D-0053-2023 |
| Aug 26, 2022 | Carolina Infusion | Semaglutide/Cyanocobalamin 24/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936. | Lack of Assurance of Sterility | Class II | Completed | D-1521-2022 |
| Aug 26, 2022 | Carolina Infusion | Semaglutide/Cyanocobalamin 5/2 MG/ML Injectable, 0.2 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936. | Lack of Assurance of Sterility | Class II | Completed | D-1519-2022 |
| Aug 26, 2022 | Carolina Infusion | Semaglutide/Cyanocobalamin 10/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936. | Lack of Assurance of Sterility | Class II | Completed | D-1520-2022 |
| Mar 7, 2022 | TMC Acquisition LLC dba Tailor Made Compounding | Semaglutide/Cyanocobalamin 5mg/0.2mg/ml, 2ml-vial, Refrigerate, Tailor Made Compounding | Lack of Assurance of Sterility | Class II | Ongoing | D-1225-2022 |
| Mar 7, 2022 | TMC Acquisition LLC dba Tailor Made Compounding | Semaglutide/Cyanocobalamin 2mg/0.4mg/ml, 1mL-vial, Refrigerate, Tailor Made Compounding | Lack of Assurance of Sterility | Class II | Ongoing | D-1224-2022 |
Recalls of FDA-approved branded products (for example Wegovy or Ozempic) and of approved generic liraglutide are outside this index; see the methodology.
This page lists recall enforcement reports as FDA publishes them through openFDA. A recall record is not a finding by this site. Class and status are FDA’s; a recall may have been completed or terminated since the date shown. Follow each link for the original record. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.